The NYU Cancer Institute takes a multidisciplinary approach to patient care and features a translational research program that brings together laboratory scientists and clinical researchers. The result: the latest advances in cancer care are delivered in a caring and compassionate setting. We are a translational cancer center. Our scientists and other
researchers share a goal of understanding how cancer develops at the molecular level, and how we can harness that knowledge to reduce the risk of cancer and to treat the disease. We constantly seek and create new opportunities for collaboration between investigators within our own walls, those located elsewhere in the New York University network of campuses (such as the Washington Square campus in lower Manhattan), and researchers at other institutions.
We take a team approach to cancer. Cancer is a complex problem requiring complex solutions. This means bringing together experts from a variety of disciplines to create collaborative research endeavors and clinical care teams. We offer the full continuum of personalized care, from prevention through diagnosis, treatment, and post-treatment support. While we offer the most up-to-date care for all cancers, we are accelerating the pace of our research and clinical care for all types of human cancer. In addition, we are now launching special emphasis
programs in cancer healthcare disparities, molecularly-targeted therapy, lung cancer, melanoma, and signaling pathways involved in cancer, such as those driven by the ras and mTOR molecules.